Weakness, MuscleNCT05967611
Hip Abductor Function During Trendelenburg Test
An observational study of Weakness, Muscle, run by Ahram Canadian University at 1 site in Egypt.
Trial summary
This study will use electromyography and dynamometry to evaluate gluteal muscle activation during the Trendelenburg hip abduction test in different hip positions. Read more about this study
- Who is it for?
- Ages 18 to 45 yearsHealthy volunteers can take part
- Conditions the study is for
- Weakness, Muscle
- What is being tested?
- Trendelenburg hip abduction test
- How many people
- 30 participants
- Where
- 1 siteEgypt
- Study dates
- 25 Jul 2023to 28 Dec 2023
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 45 years
- All sexes
- Healthy volunteers accepted
- Adult
Study population: Healthy men and women aged 18-45 recruited from the local community.
Who may be able to join
- Healthy adults aged 18-45 years
- No history of hip disorders
Who cannot join
- Contraindications to EMG
- Neurological or muscular disorders
Trial locations and contacts
1 site in 1 country.
Egypt1 site, 1 recruiting
- Recruiting
Outpatient clinic of faculty of physical therapy, Ahram Canadian University
Al Ḩayy Ath Thāmin, Giza Governorate, 3221405
Mohamed M ElMeligie, Ph.d, 01064442032, mohamed.elmeligie@acu.edu.eg
About this study
Official title: Electromyographic Evaluation of Hip Abductors During the Trendelenburg Test
This study will use electromyography and dynamometry to evaluate gluteal muscle activation during the Trendelenburg hip abduction test in different hip positions.
Read the detailed description
The Trendelenburg test is commonly used to assess hip abductor weakness. However, it is unclear which hip position during this test best isolates gluteal muscle function. This study will measure gluteus medius and minimus activation and hip abduction force in 30 healthy participants performing the Trendelenburg test. Different hip flexion, extension, adduction and abduction angles will be evaluated to determine which position optimally targets the gluteal muscles. Results may enhance utilization of the Trendelenburg test in clinical practice.
- Conditions
- Weakness, Muscle
- Being tested
- Trendelenburg hip abduction test
- Medical subject headings
- Muscle Weakness
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Trendelenburg hip abduction testDiagnostic test
The Trendelenburg test performed at different hip flexion, extension, adduction and abduction angles.
| Study group | Role | What they receive |
|---|---|---|
| Healthy Adults | At least 30 healthy adult participants aged 18-45 years performing the Trendelenburg hip abduction test Receives: Diagnostic Test: Trendelenburg hip abduction test |
What is being measured
The primary outcome is the main question the study is designed to answer.
Gluteus Medius Activation
Mean EMG activity of the gluteus medius during the Trendelenburg test at different hip positions. Measured bilaterally in microvolts (μV).
Measured: Baseline
Secondary outcomes (2)
Gluteus Minimus Activation during Trendelenburg Test
Mean muscle activation amplitude (measured in microvolts, μV) of the gluteus minimus during the Trendelenburg hip abduction test across a range of hip flexion, extension, adduction and abduction angles from 0 to 45 degrees. Measured bilaterally using surface electromyography electrodes placed on the muscle belly of the gluteus minimus.
Measured: Baseline
Hip Abduction Strength during Trendelenburg Test
Maximum voluntary isometric hip abduction strength (measured in Newtons, N) during the Trendelenburg hip abduction test maneuver. Measured bilaterally at each combination of hip flexion, extension, adduction and abduction angles using a stabilized handheld dynamometer placed just proximal to the lateral femoral condyle.
Measured: Baseline
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted1 Aug 2023
- Study start25 Jul 2023 (estimated)
- Primary completion20 Dec 2023 (estimated)
- Study completion28 Dec 2023 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Weakness, MuscleStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Other
- Time perspective
- Cross-sectional
- Enrolment
- 30 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Ahram Canadian University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Mohamed Magdy ElMeligie, Ahram Canadian University
- Investigators
- Amal Fawzy, Ph.d, Study director, Faculty of Physical Therapy, Ahram Canadian University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT05967611
- Sponsor's protocol ID
- OT-TT-001
- Status last verified
- Jul 2023
- First submitted
- 21 Jul 2023
- Last updated
- 1 Aug 2023
- Results posted
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 1 Aug 2023. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Electromyographic Evaluation of Hip Abductors During the Trendelenburg Test
- ClinicalTrials.gov ID
- NCT05967611
- Acronym / sponsor ID
- OT-TT-001
- Conditions
- Weakness, Muscle
- Study type
- Observational
- Recruitment status
- Unknown status
- Enrolment
- 30 participants (estimated)
- Lead sponsor
- Ahram Canadian UniversityUniversity, hospital or other
- Study start
- 25 Jul 2023 (estimated)
- Primary completion
- 20 Dec 2023 (estimated)
- Study completion
- 28 Dec 2023 (estimated)
- First posted
- 1 Aug 2023 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This study will use electromyography and dynamometry to evaluate gluteal muscle activation during the Trendelenburg hip abduction test in different hip positions.
Detailed description
The Trendelenburg test is commonly used to assess hip abductor weakness. However, it is unclear which hip position during this test best isolates gluteal muscle function. This study will measure gluteus medius and minimus activation and hip abduction force in 30 healthy participants performing the Trendelenburg test. Different hip flexion, extension, adduction and abduction angles will be evaluated to determine which position optimally targets the gluteal muscles. Results may enhance utilization of the Trendelenburg test in clinical practice.
Study design
- Observational model
- Other
- Time perspective
- Cross-sectional
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Healthy Adults | – | Diagnostic Test: Trendelenburg hip abduction testAt least 30 healthy adult participants aged 18-45 years performing the Trendelenburg hip abduction test |
Who may qualify
- Ages
- 18 to 45 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult
- Study population
- Healthy men and women aged 18-45 recruited from the local community.
Key inclusion criteria (2 listed)
- Healthy adults aged 18-45 years
- No history of hip disorders
Key exclusion criteria (2 listed)
- Contraindications to EMG
- Neurological or muscular disorders
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Trendelenburg hip abduction testThe Trendelenburg test performed at different hip flexion, extension, adduction and abduction angles. | Diagnostic test | Healthy Adults |
Primary outcome
Gluteus Medius Activation
Time frame: Baseline
Mean EMG activity of the gluteus medius during the Trendelenburg test at different hip positions. Measured bilaterally in microvolts (μV).
2 secondary outcomes
Gluteus Minimus Activation during Trendelenburg Test
Time frame: Baseline
Hip Abduction Strength during Trendelenburg Test
Time frame: Baseline
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 1 Aug 2023.
- Individual participant dataSharing planned: No
Related trials for Weakness, Muscle
RecruitingObservational study
Imaging Assessment of Swallowing and Speech Muscles in Inclusion Body Myositis
IBM, Inclusion Body Myositis
Recruiting
Blood Flow Restriction Training in Knee Arthropathy
Knee Arthroscopic Surgery, Arthrogenic Muscle Inhibition
Not yet recruiting
Beyond Voluntary Effort: Reliability and Validity of Magnetic Femoral Nerve Stimulation for Assessing Quadriceps Strength in Critically Ill Patient
Critical Illness, ICU-acquired Weakness
RecruitingPhase 1
Study of Anitocabtagene Autoleucel in Participants With Non-Oncology Plasma Cell-Related Diseases
Muscular Diseases, Neuromuscular Manifestations
RecruitingPhase 1/2
PBGENE-DMD Phase 1/2a Safety and Preliminary Efficacy Study in Duchenne Muscular Dystrophy (FUNCTION-DMD)
Duchenne Muscular Dystrophy With Mutations Amenable to PBGENE-DMD
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Amal Fawzy, Ph.d study director
Faculty of Physical Therapy, Ahram Canadian University
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Weakness, Muscle, run by Ahram Canadian University at 1 site in Egypt.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 2 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 1 Aug 2023. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
Contact Mohamed M ElMeligie, Ph.d (+201064442032, mohamed.elmeligie@acu.edu.eg), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Gluteus Medius Activation (time frame: Baseline). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 1 Aug 2023.